(Q37948072)

25 August 2017

1 reference

title

Neuropeptides and Alzheimer's disease (English)

1 reference

25 August 2017

0 references

Husain MM

1

1 reference

25 August 2017

Nemeroff CB

series ordinal

2

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 August 1990

1 reference

Journal of the American Geriatrics Society

25 August 2017

published in

1 reference

25 August 2017

volume

38

1 reference

25 August 2017

issue

8

1 reference

25 August 2017

page(s)

918-925

1 reference

Neuropeptides in neurological disease

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Selective loss of central cholinergic neurons in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Changes in the Monoamine Containing Neurones of the Human Cns in Senile Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Dementia--Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Behavioural and motor excitation and inhibition induced by the administration of small and large doses of somatostatin into the amygdala☆

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Neuropeptides in Alzheimer type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer-type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

High-molecular-weight forms of somatostatin are reduced in Alzheimer's disease and Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Somatostatin content and release measured in cerebral biopsies from demented patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Neuropeptides in aging and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: coexistence with neuropeptide Y neurons, and effects in Alzheimer-type dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Somatostatin-like immunoreactivity in lumbar cerebrospinal fluid from neurohistologically examined demented patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

CSF somatostatin-like immunoreactivity in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

CSF somatostatin in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

CSF somatostatin in Alzheimer's disease, depressed patients, and control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Neuropeptide Y distribution in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Modulation of memory processing by neuropeptide Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Neuropeptide coexistence in human cortical neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Neuropeptide Y-like immunoreactivity in neuritic plaques of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's-type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Cerebrospinal fluid somatostatin and neuropeptide Y. Concentrations in aging and in dementia of the Alzheimer type with and without extrapyramidal signs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and corticotropin (ACTH) are reduced in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: its relationship to severity of dementia and monoamine metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Normal pattern of labeling of cerebral cortical corticotropin-releasing factor (CRF) receptors in Alzheimer's disease: evidence from chemical cross-linking studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Central target for the behavioural effects of vasopressin neuropeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Effects of vasopressin on human memory functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Arginine vasopressin and choline acetyltransferase in brains of patients with Alzheimer type senile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Vasopressin in Alzheimer's disease: a study of postmortem brain concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

CSF and plasma vasopressin concentrations in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Cerebrospinal fluid vasopressin, oxytocin, somatostatin, and beta-endorphin in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Oxytocin, vasopressin and memory: opposite effects on consolidation and retrieval processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Oxytocin in Alzheimer's disease: postmortem brain levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Neurotensin immunoreactivity in post-mortem brain is increased in Down's syndrome but not in Alzheimer-type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Post mortem levels of thyrotropin-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Thyrotropin-releasing hormone, luteinizing hormone-releasing hormone and substance P immuno-reactivity in post-mortem brain from cases of Alzheimer-type dementia and Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Substance P-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Vasoactive intestinal polypeptide (VIP): distribution in normal human brain and in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Neuropeptides in Alzheimer's disease, depression and schizophrenia. A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

beta-Endorphin-like immunoreactivity in cerebrospinal fluid of patients with Alzheimer's disease and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Extrahypophyseal distribution of alpha-melanocyte stimulating hormone (alpha-MSH)-like immunoreactivity in postmortem brains from normal subjects and Alzheimer-type dementia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

CSF alpha-MSH in dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Corticotropin regulates trans-synaptically the activity of septo-hippocampal cholinergic neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Galanin-like immunoreactivity in cholinergic neurons of the septum-basal forebrain complex projecting to the hippocampus of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1990.TB05710.X

10.1111/J.1532-5415.1990.TB05710.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference